Fluorodeoxyglucose PET Scans in the Integrative Medicine Setting.
Publication/Presentation Date
10-1-2026
Abstract
Functional imaging with fluorodeoxyglucose (FDG) PET has substantially advanced our understanding of the biological processes underlying a wide range of neurologic and systemic disorders. In particular, brain FDG PET enables the visualization of regional metabolic activity associated with different mental states and neuropsychiatric conditions. By assessing patterns of cerebral glucose metabolism, FDG PET can provide insight into an individual's current brain function, including age-related metabolic changes and early alterations suggestive of neurodegenerative disorders such as Alzheimer's disease. This article reviews potential indications for FDG PET scanning in integrative medicine practice and situates it within the broader landscape of functional imaging modalities.
Volume
21
Issue
4
First Page
573
Last Page
585
ISSN
1879-9809
Published In/Presented At
Newberg, A. B., Hua, Y., Ayubcha, C., & Monti, D. A. (2026). Fluorodeoxyglucose PET Scans in the Integrative Medicine Setting. PET clinics, 21(4), 573–585. https://doi.org/10.1016/j.cpet.2026.06.001
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
42420092
Department(s)
Administration and Leadership
Document Type
Article